Relative Bioavailability of Tablet Formulation of Dabigatran Etexilate With and Without Co-administration of Rabeprazole in Healthy Male Subjects (an Open-label, Single-dose, Two-period, Single-arm Study)
Phase of Trial: Phase I
Latest Information Update: 21 Aug 2017
At a glance
- Drugs Dabigatran etexilate (Primary) ; Rabeprazole
- Indications Deep vein thrombosis; Embolism; Pulmonary embolism; Venous thromboembolism
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 16 Aug 2017 Status changed from recruiting to completed.
- 01 Jun 2017 Status changed from not yet recruiting to recruiting.
- 10 May 2017 New trial record